Confidentiality and Trade Secrets: Articles 103-104 of the Tıbbi Cihaz Yönetmeliği, Personal Data and Publicly Available Information in EUDAMED

SUMMARY
Confidentiality and trade secrecy are regulated in Article 103 of the Tıbbi Cihaz Yönetmeliği (Medical Device Regulation). All parties involved in the application of the regulation respect the confidentiality of the information and data they obtain in carrying out their tasks; under Article 104, the Kişisel Verilerin Korunması Kanunu (Personal Data Protection Law) applies to the processing of personal data.
In this article we give Articles 103 and 104, the information publicly available in EUDAMED, the confidentiality obligation of notified bodies, the confidentiality of clinical investigation information, the counterpart in the IVD Regulation and the ÜTS side, with word-for-word quotations from the regulation text.
For your ÜTS and EUDAMED registrations: Medical Device ÜTS Registration Consultancy
Contents
1. Article 103: The Confidentiality Obligation
Paragraph one of Article 103 of the Tıbbi Cihaz Yönetmeliği:
“(1) Unless otherwise indicated in this Regulation and without prejudice to existing provisions and practices on confidentiality, all parties involved in the application of this Regulation shall;”
“(a) protect personal data in accordance with Article 104,”
“(b) protect commercially confidential information and professional secrets of a natural or legal person, including intellectual property rights, unless disclosure is in the public interest,”
“(c) ensure the effective implementation of this Regulation, in particular for the purposes of inspections, investigations or audits,”
“respect the confidentiality of information and data obtained in carrying out their tasks.”
Addressee of the obligation: all parties involved in the application of the regulation.
Protected: personal data, commercially confidential information and professional secrets (including intellectual property rights).
Limit: the wording “unless disclosure is in the public interest” in point (b).
2. Sharing between Authorities and Reserved Cases
Paragraphs two and three of Article 103:
“(2) Without prejudice to the first paragraph, information exchanged on a confidential basis between the competent authorities or the Commission and the Agency shall not be disclosed without the prior agreement of the authority that originated it.”
“(3) The first and second paragraphs shall not affect the rights and obligations of the Agency and notified bodies with regard to the exchange of information and the dissemination of warnings, nor the obligations of the persons concerned to provide information in judicial proceedings.”
Under the third paragraph, the confidentiality provisions do not affect the rights and obligations of the Agency and notified bodies with regard to the exchange of information and the dissemination of warnings, or the obligations to provide information in judicial proceedings.
3. Article 104: Protection of Personal Data
“(1) In the processing of personal data under this Regulation, the Kişisel Verilerin Korunması Kanunu (Personal Data Protection Law) and other legislation on the protection of personal data apply.”
For personal data in EUDAMED, the fifth paragraph of Article 33 also states:
“(5) EUDAMED shall include personal data only insofar as necessary for the electronic systems referred to in the second paragraph to collect and process information in accordance with this Regulation. Personal data shall be kept in a form which permits identification of data subjects for periods not exceeding those referred to in the eighth paragraph of Article 10.”
4. Which Information Is Publicly Available in EUDAMED?
The fourth paragraph of Article 33 sets the general rule on access:
“(4) All information collated and processed by EUDAMED shall be accessible to the competent authorities and the Commission. The information shall be accessible to notified bodies, economic operators, sponsors and the public to the extent specified in the provisions on the electronic systems referred to in the second paragraph.”
Public availability is determined in the article on each electronic system. Examples:
UDI database (Art. 28): the core data elements in Part B of Annex VI are publicly available free of charge.
Registration of economic operators (Art. 31/7): the data entered in the electronic system in Article 30 is publicly available.
Summary of safety and clinical performance (Art. 32): publicly available through EUDAMED.
Notified bodies and certificates (Art. 57/2): publicly accessible as specified in the regulation.
“(7) The data entered into the electronic system referred to in Article 30 in accordance with the first paragraph shall be publicly available.”
The third paragraph of Article 97 sets a limit for market surveillance information:
“(3) Where making public the information exchanged between the Agency and other competent authorities is likely to harm market surveillance and inspection activities and cooperation between competent authorities, such information shall not be made public.”
For the EUDAMED modules, see our pages on what is EUDAMED and EUDAMED device registration.
5. Confidentiality in Clinical Investigation Information
Under the second paragraph of Article 73, the information in the clinical investigation electronic system is publicly available unless confidentiality is justified. The grounds are:
“(a) Protection of personal data in accordance with the relevant legislation.”
“(b) Unless disclosure is required in the public interest, protection of commercially confidential information, in particular that in the investigator's brochure, by taking into account the conformity assessment status of the device.”
“(c) Effective supervision of the conduct of the clinical investigation by the relevant EU member state(s) and/or Türkiye.”
“(3) No personal data of subjects shall be publicly available.”
For investigational devices, see our article on clinical investigation and investigational device.
6. Confidentiality Obligation of the Notified Body and the Agency
Point 1.3 of Annex VII:
“1.3.1. The notified body shall have documented procedures in place ensuring that its personnel, committees, subsidiaries/branches, subcontractors and the personnel of external bodies, or any associated body, respect the confidentiality of the information which comes into their possession during the performance of conformity assessment activities, except when disclosure is required by law.”
For the Agency as the authority responsible for notified bodies, the fifth paragraph of Article 35:
“(5) The Agency shall protect the confidential aspects of the information it obtains. However, it shall exchange information on notified bodies with EU member states, the Commission and, where necessary, other regulatory authorities.”
7. Transfer of Documents upon Change of Authorized Representative and Notified Body
The contract or agreement to be made on a change of authorized representative (Art. 12) and on a voluntary change of notified body (Art. 58) regulates the transfer of documents:
“(c) The transfer of documents, including confidentiality principles and property rights.”
“(c) The transfer of documents, including confidentiality aspects and property rights,”
For the responsibilities of the authorized representative, see our article on authorized representative authorization certificate and responsibility, and for the change of notified body, see our article on change of notified body.
8. For IVD Devices and on the ÜTS Side
In the İn Vitro Tanı Amaçlı Tıbbi Cihaz Yönetmeliği (In Vitro Diagnostic Medical Device Regulation), confidentiality is in Article 100 and the protection of personal data is in Article 101. The first point of Article 100:
“(a) protect personal data in accordance with Article 101,”
The TİTCK ÜTS Registration Guide (TCKKD-KLVZ-03) has no separate provision on confidentiality or trade secrets. Under Article 34 of the Tıbbi Cihaz Yönetmeliği, the ÜTS obligations are determined by the Agency's regulations:
“(2) The said obligations relating to ÜTS are determined by the regulations published by the Agency.”
On the advertising side, Article 15 of the guide TCS-KLVZ-08 (the guide to the Sales, Advertising and Promotion Regulation) contains the following provision:
“(8) Advertising activity cannot be carried out in a manner that violates the privacy of private life or discloses personal data.”
9. Frequently Asked Questions
Are trade secrets in the technical documentation protected?
Under point (b) of Article 103, all parties involved in the application of the regulation protect commercially confidential information and professional secrets, including intellectual property rights, unless disclosure is in the public interest.
Does confidentiality prevent the dissemination of warnings?
No. Under the third paragraph of Article 103, the confidentiality provisions do not affect the rights and obligations of the Agency and notified bodies with regard to the dissemination of warnings.
Which legislation applies to personal data?
Under Article 104, the Kişisel Verilerin Korunması Kanunu (Personal Data Protection Law) and other legislation on the protection of personal data apply.
Is the actor information entered in EUDAMED publicly available?
Under the seventh paragraph of Article 31, the economic operator data entered in the electronic system referred to in Article 30 is publicly available.
Are subject data published in a clinical investigation?
No. Under the third paragraph of Article 73, no personal data of subjects is publicly available.
For your ÜTS and EUDAMED registrations: Medical Device ÜTS Registration Consultancy
Sources



